Our Coverage of the Race to Develop a COVID-19 Vaccine
As several COVID-19 vaccine candidates are now in the late phase of clinical trials, MHE is sharing a few stories that have covered the infamous virus' vaccine development journey.
Several candidates for a COVID-19 vaccine are now in late-phase clinical trials, and the world is eagerly awaiting results. Managed Healthcare Executive® has covered the race to develop a safe and effective vaccine from the beginning of the pandemic.
Here are a few of our top stories:
- Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners
FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.
- ICER's Gaze Turns to COVID Vaccine, Treatment Prices
The Institute for Clinical and Economic Review (ICER) is jumping into the fray of putting a price on what the world is waiting for — a safe, effective COVID-19 vaccine.
- The Pharmaceutical Industry’s Role in a COVID-19 Vaccine
Drug makers around the world are racing to develop the first effective COVID-19 vaccine. Early efforts show promise, but an anticipated jump in the novel coronavirus cases in the fall means the sooner a vaccine is developed, the more lives can be saved-and the pharmaceutical industry plays a major role in this discovery.
- An Update on COVID-19 Vaccine Development
A safe, effective vaccine by December 2020 or January 2021?
-The Search is on For Treatment Drugs and a Vaccine
Testing remains ongoing in the search for treatment drugs and a vaccine for COVID-19.
Related to the coverage of the race to develop a COVID-19 vaccine, MJH Life Sciences will be hosting a COVID-19 vaccine webinar 7/30 at 6 pm ET. Panelists will review the top vaccine candidates & discuss how to combat the logistical challenges of rolling out a vaccine during a global pandemic. Learn more & register here.
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
